Biotech Showcase At Jpm 2025. JPM 2025 Annual Healthcare Conference 2025 Dan Mendelson is the Chief Executive Officer of Morgan Health at JPMorgan Chase & Co Home / Resources / Conferences / JP Morgan Healthcare Conference and Biotech Showcase 2025 JP Morgan Healthcare Conference and Biotech Showcase 2025
More Than 3,300 Attendees and 1,300 Investors Expected at Biotech Showcase™ 2024 During from www.businesswire.com
Our agenda features thought-provoking panels and discussions with industry leaders, investors, and innovators, covering the most relevant and transformative topics in biotech today. Mendelson oversees a business unit at JPMorgan Chase focused on accelerating the delivery of new care models that improve the quality, equity and affordability of employer-sponsored healthcare.
More Than 3,300 Attendees and 1,300 Investors Expected at Biotech Showcase™ 2024 During
Additionally, this pass also grants you access to digital one-to-one. Flexible solutions for biotech companies at every value inflection point Biotech Showcase™, the investor conference in San Francisco produced by Demy-Colton and EBD Group, is devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to investors and pharmaceutical executives.
Gene Therapy Archives Commetric. Sörensen, CEO, will together with Rahul Agrawal, Chief Medical Officer and Head of R&D and Jeppe Øvlesen, Board Member, participate at the well-attended investor and networking event Biotech Showcase 2025 Biotech Showcase is a premier investor conference that takes place during the busiest week in life sciences
J.P. Healthcare Conference & Biotech Showcase™ 2023 & JPMBIO 파멥신. Registration Access to Partnering Platform Now Open Flexible solutions for biotech companies at every value inflection point